(PRESS RELEASE) AMSTERDAM, 14-Dec-2021 — /EuropaWire/ — Royal Philips (NYSE: PHG; AEX: PHIA), a global leader in health technology, has announced the acquisition of Vesper Medical Inc., a US-based medical technology company that develops minimally-invasive peripheral vascular devices. The acquired … Read the full press release
Posted in Business, Healthcare, Netherlands, News, Pharma & Biotech, Science, Technology
Tagged acquisition, advanced venous stent, Bruce Shook, Chris Landon, deep venous disease, diagnostic, health technology, Intact Vascular, intravascular ultrasound, IVUS catheters, live 2D/3D interventional imaging, medical technology, PAD, peripheral artery disease, peripheral atherectomy devices, peripheral therapy devices, peripheral vascular, peripheral vascular devices, Royal Philips, therapeutic devices, venous imaging, Vesper Medical, Vesper Medical Inc
research also points to diabetes as cause of disease that can lead to limb amputation DUNDEE, 20-Sep-2017 — /EuropaWire/ — Smoking and diabetes are the two leading risk factors for peripheral artery disease (PAD), a narrowing of the arteries which can … Read the full press release
Posted in Education, Healthcare, Society, United Kingdom
Tagged Diabetes, peripheral artery disease, Professor Metin Avkiran, smoking, University of Dundee
Expands Treatment Options for Patients in Europe with Peripheral Artery Disease Both Above and Below the Knee DUBLIN, 25-Jan-2017 — /EuropaWire/ — Medtronic plc (NYSE: MDT) today announced CE (Conformité Européene) Mark approval for the HawkOne(TM) directional atherectomy system in a … Read the full press release
New Technology Expands Treatment Options for Patients with Peripheral Artery Disease Both Above and Below the Knee DUBLIN, 27-Oct-2016 — /EuropaWire/ — Medtronic plc (NYSE: MDT) has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the HawkOne(TM) Directional Atherectomy … Read the full press release
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
